ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GALT Galectin Therapeutics Inc

3.35
-0.12 (-3.46%)
May 07 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 41.83M33.62M25.89M17.91M21.29M20.23M20.08M22.16M
Total Current Assets 41.82M33.51M25.79M17.12M20.55M19.55M19.47M21.61M
Cash and Equivalents 39.65M31.61M24.18M15.83M18.59M17.8M17.97M20.36M
Total Non-Current Assets 7k108k101k793k733k673k613k552k
Total Liabilities 39.21M39.81M41.11M40.25M53.48M62.87M71.21M73.04M
Total Current Liabilities 9.03M9.54M10.89M9.59M13.01M11.53M9.95M10.52M
Total Non-Current Liabilities 59.23M59.55M59.72M60.4M80.3M101.28M121.61M123.65M
Common Equity 586k586k569k569k569k569k569k571k
Retained Earnings -270.69M-280.61M-290.29M-298.87M-309.57M-321.09M-330.27M-344.31M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 15.8M4.16M9.01M48.47M29.6M41.83M21.29M28.2M
Total Current Assets 15.79M3.82M8.83M48.21M29.47M41.82M20.55M27.71M
Cash and Equivalents 15.36M3.05M8.25M47.48M27.14M39.65M18.59M25.66M
Total Non-Current Assets 10.29M-530k5.18M43.87M22.47M893k-33.92M-61.96M
Total Liabilities 5.5M2.97M2.11M2.87M5.41M39.21M53.48M88.44M
Total Current Liabilities 3.78M2.97M2.11M2.82M5.4M9.03M13.01M15.68M
Total Non-Current Liabilities 1.72M0052k8k59.23M80.3M144.51M
Total Equity 10.29M-530k5.18M43.87M22.47M893k-33.92M-61.96M
Common Equity 7.27M7.28M7.26M593k583k586k569k561k
Retained Earnings -163.7M-181.17M-196.22M-216.39M-240M-270.69M-309.57M-354.37M

Your Recent History

Delayed Upgrade Clock